Optimizing MOAs of JAK Inhibitors in a 36-Year-Old Male With a History of Atopic Dermatitis
August 20th 2024Jayme Heim, MSN, FNP-BC, explores strategies for optimizing the mechanisms of action of topical JAK inhibitors in treating a 36-year-old male patient with a history of atopic dermatitis, highlighting the potential benefits and considerations of this therapeutic approach.
Frontline Forum Part 3: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Frontline Forum Part 2: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, topical formulations and epidermal barrier dysfunction, and more.
Frontline Forum Part 1: Topical Therapy for Corticosteroid-Responsive Dermatoses
Experts discuss enhancing patient outcomes, the "mounting mutiny" against topicals, and more.